AliveCor Announces Collaboration With AstraZeneca To Develop Non-Invasive Potassium Monitoring Solutions

AliveCor, the leader in AI-based personal electrocardiogram (ECG) technology and provider of enterprise cardiology solutions, announced a new collaboration with AstraZeneca, a global science-led biopharmaceutical company, to research new disease management solutions in cardiovascular, renal, and metabolism (CVRM) therapeutic areas. The collaboration will translate AliveCor’s potassium detection technology and science, which enables potassium measurement outside of blood draws, into real-world disease management applications and solutions.

The cross-industry collaboration expands the research and development of AliveCor’s Kardia-K AI platform, which received “Breakthrough Device Designation” status from the U.S. Food and Drug Administration (FDA . . .